Date & Time
August 18, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
About the Event
The first challenge in treating the millions of people who suffer from Central Nervous System (CNS) diseases like Alzheimer’s, Parkinson’s, Multiple Sclerosis, and acute events like Strokes is delivering targeted therapies into the brain.
Aruna Bio has made it past that first hurdle with AB126, a novel neural anti-inflammatory and neuromodulator that naturally crosses the Blood/Brain Barrier and in trials shows great promise as an effective treatment for stroke.
Join our webinar to learn more about Aruna’s innovative new drug platform and how it can be used to deliver a wide variety of therapeutics to the brain.